Spots Global Cancer Trial Database for Prevention of Paclitaxel Neuropathy With Cryotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Prevention of Paclitaxel Neuropathy With Cryotherapy
Official Title: Prevention of Paclitaxel Neuropathy With Cryotherapy
Study ID: NCT02230319
Conditions
Study Description
Brief Summary: The purpose of this study is to determine if cryotherapy can effectively decrease the rate of neuropathy in patients undergoing weekly paclitaxel treatments.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Medical Oncology & Hematology Associates of Northern Virginia, Fairfax, Virginia, United States
Medical Oncology & Hematology Associates of Northern Virginia, Reston, Virginia, United States
Contact Details
Name: Mary J Wilkinson, MD
Affiliation: Medical Oncology & Hematology Associates of Northern Virginia
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
